Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$4.68 - $9.26 $59,712 - $118,148
-12,759 Reduced 31.89%
27,251 $136,000
Q2 2023

Aug 04, 2023

BUY
$8.5 - $10.38 $24,352 - $29,738
2,865 Added 7.71%
40,010 $365,000
Q1 2023

May 11, 2023

SELL
$7.53 - $10.95 $7,673 - $11,158
-1,019 Reduced 2.67%
37,145 $351,000
Q4 2022

Feb 07, 2023

SELL
$9.44 - $13.09 $43,735 - $60,645
-4,633 Reduced 10.83%
38,164 $380,000
Q3 2022

Nov 10, 2022

SELL
$8.14 - $12.25 $887 - $1,335
-109 Reduced 0.25%
42,797 $510,000
Q2 2022

Aug 03, 2022

BUY
$6.99 - $10.0 $8,297 - $11,870
1,187 Added 2.85%
42,906 $351,000
Q1 2022

May 04, 2022

SELL
$7.26 - $10.7 $3,709 - $5,467
-511 Reduced 1.21%
41,719 $331,000
Q4 2021

Feb 04, 2022

BUY
$8.8 - $16.0 $160,767 - $292,304
18,269 Added 76.24%
42,230 $396,000
Q3 2021

Oct 07, 2021

BUY
$15.23 - $21.72 $7,843 - $11,185
515 Added 2.2%
23,961 $379,000
Q2 2021

Aug 04, 2021

SELL
$17.8 - $23.5 $85,600 - $113,011
-4,809 Reduced 17.02%
23,446 $507,000
Q1 2021

May 04, 2021

SELL
$17.18 - $22.6 $198,257 - $260,804
-11,540 Reduced 29.0%
28,255 $572,000
Q4 2020

Feb 02, 2021

SELL
$11.5 - $17.96 $71,530 - $111,711
-6,220 Reduced 13.52%
39,795 $712,000
Q3 2020

Oct 09, 2020

BUY
$10.62 - $13.12 $9,961 - $12,306
938 Added 2.08%
46,015 $535,000
Q2 2020

Jul 08, 2020

BUY
$7.35 - $10.81 $68,737 - $101,095
9,352 Added 26.18%
45,077 $417,000
Q1 2020

Apr 23, 2020

BUY
$8.38 - $17.34 $51,118 - $105,774
6,100 Added 20.59%
35,725 $372,000
Q4 2019

Feb 11, 2020

BUY
$11.18 - $18.6 $13,035 - $21,687
1,166 Added 4.1%
29,625 $530,000
Q3 2019

Oct 17, 2019

SELL
$12.09 - $20.46 $4,110 - $6,956
-340 Reduced 1.18%
28,459 $355,000
Q2 2019

Aug 02, 2019

BUY
$18.5 - $25.47 $532,781 - $733,510
28,799 New
28,799 $570,000
Q3 2018

Nov 14, 2018

SELL
$34.05 - $55.9 $5,584 - $9,167
-164 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$36.15 - $52.5 $5,928 - $8,610
164 New
164 $8,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $763M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.